As. Brem et Dj. Morris, INTERACTIONS BETWEEN GLUCOCORTICOIDS AND MINERALOCORTICOIDS IN THE REGULATION OF RENAL ELECTROLYTE TRANSPORT, Molecular and cellular endocrinology, 97(1-2), 1993, pp. 30000001-30000005
The enzyme 11 beta-hydroxy steroid dehydrogenase (11 beta-OHSD) was de
scribed and its location in various organs noted more than 30 years ag
o (Mahesh and Ulrich, 1960; Jenkins, 1966). 11 beta-OHSD inactivates c
irculating glucocorticoids by transforming the hydroxyl group at the 1
1-carbon to a keto group. This chemical reaction has taken on a greate
r degree of physiologic and clinical significance in recent years. It
has been suggested that 11 beta-OHSD, present in mineralocorticoid tar
get tissues, can act as a ''guardian'' over the mineralocorticoid rece
ptor by transforming circulating endogenous glucocorticoids to their r
espective ''biologically inert'' ll-dehydro derivatives (Edwards et al
., 1988; Funder et al., 1988). These derivatives do not bind to minera
locorticoid receptors (MR) while both their parent compounds and miner
alocorticoids bind to cloned MR with equal affinity (Arriza et al., 19
87). 11 beta-OHSD has generated a growing sense of scientific exciteme
nt since this enzyme may represent one of a family of metabolic pathwa
ys or mechanisms which can regulate steroid induced renal reabsorption
of sodium. Such ''protective'' enzymatic pathways, present in the kid
ney and elsewhere, may not only control the access of glucocorticoids
to MR, but control the access of glucocorticoids to glucocorticoid rec
eptors (GR) (Teelucksingh et al., 1990; Mender, 1990) as well as acces
s of mineralocorticoids to their own receptors. This review will focus
on this concept of a family of protective enzymatic pathways and the
possible physiological implications.